Infant Formula Testing Market is expected grow at a CAGR of 6.9% to reach revenue of $20.26b
Asia-Pacific holds a major share in the Infant Formula Testing Market, followed by Americas. Rest of the world includes Middle East and Africa. Increase in product introductions and establishment of new regulations drives the growth of RoW. The Asia-Pacific region is driven by large economic developments in China and other developing countries. China is the largest market in Asia-Pacific, with a share of 26.5% in the market. Asia Pacific will experience a growth of $53.4 million by 2023 with a CAGR of 7.9%. Americas has a huge penetration of baby formula ingredients which drives the need for adulteration testing to be carried out, so that contamination is avoided and labelling is enhanced through proper nutritional analysis.
★
★
★
★
★
89 views • 7 slides
